• Kabaka@lemmy.blahaj.zone
          link
          fedilink
          English
          arrow-up
          7
          arrow-down
          1
          ·
          8 months ago

          Nobody was saying it would be. The headline and article are about production costs at different scales, not prices for anyone buying it after that.

          Hill had calculated a generic price of $40 annually last year, but said the interest from generic manufacturers had warranted new analysis. This showed lenacapavir could be mass produced for $35 to $46 a year, if there was annual demand for 2m doses, falling to $25 at scaled up production of 5m to 10m doses each year.

          Oh wait, I missed a line where the article actually suggests this…

          Dr Hill’s research indicates that this gamechanging innovation could – within a year of launch – be produced and sold for just $25 per person per year.

          But you’re right, they won’t sell it for $0 of profit. It would be nice.

          • Etterra@discuss.online
            link
            fedilink
            English
            arrow-up
            8
            ·
            8 months ago

            No they’ll sell it for 50x what an annual treatment regimen costs. That way they can grind down the desperate and still profit off the rich.

          • Bakkoda@sh.itjust.works
            link
            fedilink
            English
            arrow-up
            1
            ·
            8 months ago

            FDA can grant exclusivity to that drug. And then once there’s finally a generic that can also be granted a one year exclusivity. The FDA facilitates scarcity.

  • AmazingAwesomator@lemmy.world
    link
    fedilink
    arrow-up
    37
    ·
    8 months ago

    i understand that if it costs $25 to make it then it needs to cost a bit more for supply chain, profits etc (regularly a 50% increase from factory and another 50% increase to retail), but i’ll bet you a $500 bottle of HIV-ending drugs that this wont cost $56.25.

    • Zenith@lemm.ee
      link
      fedilink
      arrow-up
      13
      ·
      8 months ago

      $500 a bottle would be practically giving it away in the US. Most life sustaining meds or the rare cure are sold at unfathomable prices. One of my post-transplant anti rejection meds is $60,000 a month

    • foggy@lemmy.world
      link
      fedilink
      arrow-up
      6
      arrow-down
      1
      ·
      8 months ago

      Let’s call it $100 per head.

      Hey Elon, you wanna leave behind a legacy that doesn’t suck?

      Here’s your last chance, asshole.

  • Etterra@discuss.online
    link
    fedilink
    English
    arrow-up
    38
    arrow-down
    1
    ·
    8 months ago

    Well that’ll never happen - not when the drug companies can sell $2000 a month or die medication to the inflicted for the rest of their lives.

  • catty@lemmy.worldBanned
    link
    fedilink
    arrow-up
    32
    arrow-down
    1
    ·
    8 months ago

    Can we hurry up with this please. I want to cum buckets in my femboy slut. OK, thx, bye.

      • tehn00bi@lemmy.world
        link
        fedilink
        arrow-up
        1
        ·
        8 months ago

        If this shot were to become common in the gay community, would that just leave the IV drug community to be the main transmitter of HIV? Could we potentially see HIV effectively eradicated?

        • null_dot@lemmy.dbzer0.com
          link
          fedilink
          English
          arrow-up
          1
          ·
          8 months ago

          I don’t really know bit my supposition would be that eradication isn’t really on the table presently.

          This is only a prophylactic. There are people right now with HIV who (excluding a “cure” emerging) will be potentially infectious in 40 or 50 years.

          In the short to medium term making this accessible to populations in areas with a high prevalence could avoid millions of infections.

      • Ernest@lemmy.zip
        link
        fedilink
        arrow-up
        5
        ·
        8 months ago

        It looks like that’s indeed the case, and they’ve been around long enough that Handmaid’s probably wasn’t that well-known at the time. Still, the irony is off the charts… have they considered changing their logo to the traditional four-armed rotationally-symmetric sacred Buddhist symbol? >.>

    • Ledericas@lemm.ee
      link
      fedilink
      English
      arrow-up
      2
      ·
      8 months ago

      the company has been around for a long time, before the book was made famous, one of the first things i saw when applying to lab/biotech was gilead position for scientists. this was already 10 years ago.

      they even have transportaiton buses from our city to thier campuses, because its quite far away from a city if you work in biotech.

  • Wahots@pawb.social
    link
    fedilink
    arrow-up
    10
    ·
    8 months ago

    This is the drug I’m super hyped about. Even if it was $35, it would be life-changing for millions of people.

    • Chloé 🥕@lemmy.blahaj.zone
      link
      fedilink
      arrow-up
      4
      ·
      8 months ago

      you’re thinking too small

      1000$/year baybeee!

      or rather, they’ll find the perfect balance of profitability, between how many people can afford it VS how much they’d pay for it

      the poors will die but that is a sacrifice they are enthusiastic to make